The Latest: Johnson & Johnson single shot awaits approval
WASHINGTON – An analysis by U.S. regulators say Johnson & Johnson’s single-dose vaccine protects against COVID-19. The report Wednesday confirmed the vaccine is about 66% effective overall at preventing moderate to severe COVID-19. On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend… Read More »